Lidocaine Pain Relief Roll-on Liquid
FDA Label NDC 0395-9130

9 label sections · Submitted to the FDA by Humco Holding Group, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Humco Holding Group, Inc. for the product Lidocaine Pain Relief Roll-on (NDC 0395-9130). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding dosage & administration, inactive ingredient, otc - active ingredient, warnings, otc - keep out of reach of children, indications & usage, otc - purpose, cvs label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Dosage & Administration

→ Inactive Ingredient

→ Otc - Active Ingredient

→ Warnings

→ Otc - Keep Out Of Reach Of Children

→ Indications & Usage

→ Otc - Purpose

→ Cvs Label

→ Equate Label

Dosage & Administration

Adults and children 2 years of age and older: apply to the affected area no more than 3 to 4 times daily.

Children under 2 years of age: consult a doctor.

Inactive Ingredient

acrylates/C10-30 alkyl acrylate crosspolymer, aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, methylparaben, polysorbate 60, SD alcohol 40 (15%), steareth-2, steareth-21, water